1 Min Read
LONDON, April 22 (Reuters) - GlaxoSmithKline Plc : * GSK and Theravance announce regulatory submission for Anoro Ellipta
(UMEC/Vi) in Japan * Intends to commence global regulatory submissions for UMEC monotherapy later
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.